P. Duncan

Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy

G. Lander, B. Carragher, C. Potter, 2014, Human vaccines & immunotherapeutics.

BioCompute Objects to communicate a viral detection pipeline with potential for use in a regulatory environment

Danny A. Bitton, Geoffrey D. Hannigan, Janisha A. Patel, 2021, bioRxiv.

Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products.

P. Duncan, J. Sadoff, A. Schmidt, 2014, Vaccine.

Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus

P. Duncan, T. Tagmyer, C. Ranucci, 2011, PDA Journal of Pharmaceutical Science and Technology.

Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection

Arifa S Khan, Zhihui Yang, Christophe Lambert, 2018, Viruses.

Assessing the viability of a clumpy mnn9 strain of Saccharomyces cerevisiae used in the manufacture of recombinant pharmaceutical proteins

P. Tsai, P. Duncan, S. Gallagher, 2004, Journal of Industrial Microbiology and Biotechnology.

Role of Analytics in Viral Safety

Rebecca L. Sheets, Paul A. Duncan, P. Duncan, 2014, Vaccine Analysis: Strategies, Principles, and Control.

Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines.

E. Brown, P. Duncan, J. Lewis, 2006, Developments in biologicals.